Clinical data suggest this produces greater average weight loss compared to semaglutide alone
Safety signals identified through extended follow-up include: Gastrointestinal effects : Nausea, vomiting, and diarrhea remain the most common adverse events, typically diminishing over time but causing discontinuation in approximately 57% of patients Gallbladder disease : Increased incidence of cholelithiasis and cholecystitis, possibly associated with weight loss, though the exact mechanism remains under investigation Diabetic retinopathy : Risk of complications, particularly with rapid glycemic improvement in patients with pre-existing retinopathy Acute kidney injury : Risk associated with severe gastrointestinal adverse events leading to dehydration Pancreatitis : Rare cases reported, though causality remains uncertain
This means that Ipamorelin will directly lead to an increase in Growth Hormone production
K.TalalayP
In some studies, aggressivity is only observed during specific phases of circadian rhythm (Bergamini et al., 2022
Massicano AVF, Marquez-Nostra BV, Lapi SE
